Literature DB >> 15209386

Inhibition of HLA-G production in JEG-3 choriocarcinoma cells by RNA interference.

Tobias Wengenmayer1, Tobias G Poehlmann, Udo R Markert.   

Abstract

Human leukocyte antigen-G (HLA-G) plays a major role in escape of trophoblast cells from maternal cytotoxicity. Unless its malignant transformation, Jeg-3 choriocarcinoma cell line maintained the capacity of HLA-G production. For the analysis of function and mechanisms of HLA-G-induced immune regulation, a human cellular model with suppressed HLA-G would be very helpful. RNA interference (RNAi) is a very elegant method for this approach, but the design of appropriate oligonucleotide sequences may provide difficulties. We designed oligonucleotides to interfere exclusively with HLA-G mRNA, which were applied at different concentrations to 50% confluent Jeg-3 cells. After 36 hr, the HLA-G content in Jeg-3 cells was analyzed by Western blots. Applying the described RNAi method and oligonucleotides the cellular content of HLA-G was dose-dependently reduced as assessed in several independent Western blots. This method provides a tool for extensive investigation of HLA-G functions in vitro and if vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15209386     DOI: 10.1111/j.1600-0897.2004.00150.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  3 in total

Review 1.  Nanoparticles targeting HLA-G for gene therapy in cancer.

Authors:  Ines Zidi; Nidhal Ben Amor
Journal:  Med Oncol       Date:  2011-04-17       Impact factor: 3.064

2.  Suppression of Mamu-AG by RNA interference.

Authors:  Jessica G Drenzek; Jolanta Vidiguriene; Geminis Vidiguris; Richard L Grendell; Svetlana V Dambaeva; Maureen Durning; Thaddeus G Golos
Journal:  Am J Reprod Immunol       Date:  2009-04-22       Impact factor: 3.886

Review 3.  The Molecular and Functional Characteristics of HLA-G and the Interaction with Its Receptors: Where to Intervene for Cancer Immunotherapy?

Authors:  Jiji V D Attia; Charlotte E Dessens; Ricky van de Water; Ruben D Houvast; Peter J K Kuppen; Daniëlle Krijgsman
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.